Clinical trial

Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting…

NCT00418067 · Seung-Jung Park, Other · Completed

Key facts

NCT number NCT00418067
Title Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions
Official title Comparison of the Efficacy and the Safety of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions
Acronym ZEST
Lead sponsor Seung-Jung Park, Other
Collaborators Medtronic Vascular Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Coronary Artery Disease
Intervention type Device
Interventions Endeavor, Cypher, Taxus Liberte
Enrollment 2,645
Start date Oct 1, 2006
Primary completion Jan 1, 2009
Completion Jan 1, 2009
First posted Jan 4, 2007
Last update posted Aug 21, 2012
Countries South Korea

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies